| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.002 | 5.839 | 152.656 | 17.608 | 7.884 | 5.878 | 1.480 | 68 | 0 | 0 |
| Total Income - EUR | 31.489 | 1.803 | 158.880 | 6.998 | 7.049 | 916 | 2.844 | 2.686 | 0 | 0 |
| Total Expenses - EUR | 36.962 | 16.774 | 157.530 | 5.585 | 11.847 | 8.660 | 8.240 | 2.742 | 0 | 0 |
| Gross Profit/Loss - EUR | -5.473 | -14.970 | 1.349 | 1.413 | -4.798 | -7.744 | -5.396 | -57 | 0 | 0 |
| Net Profit/Loss - EUR | -6.344 | -15.088 | 1.072 | 1.102 | -4.877 | -7.800 | -5.411 | -57 | 0 | 0 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Sigvital Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.467 | 230 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 26.794 | 14.861 | 19.636 | 14.674 | 9.807 | 637 | 220 | 154 | 153 | 153 |
| Inventories | 15.305 | 11.061 | 16.930 | 6.009 | 5.058 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.793 | 1.058 | 1.330 | 7.215 | 45 | 42 | 41 | 47 | 46 | 46 |
| Cash | 5.696 | 2.742 | 1.376 | 1.450 | 4.705 | 594 | 179 | 107 | 107 | 106 |
| Shareholders Funds | 17.096 | 1.834 | 2.876 | 3.925 | -1.028 | -8.808 | -14.024 | -14.125 | -14.081 | -14.003 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.165 | 13.257 | 16.760 | 10.748 | 10.835 | 9.445 | 14.244 | 14.278 | 14.235 | 14.155 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Sigvital Med S.r.l.